• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解析细菌应激反应:对新一代抗菌解决方案的启示。

Unraveling bacterial stress responses: implications for next-generation antimicrobial solutions.

机构信息

Department of Bioengineering, Faculty of Engineering and Natural Sciences, Üsküdar University, Istanbul, Türkiye.

Genetics of Prokaryotes, Faculty of Biology and Center for Biotechnology (CeBiTec), Bielefeld University, Bielefeld, Germany.

出版信息

World J Microbiol Biotechnol. 2024 Jul 29;40(9):285. doi: 10.1007/s11274-024-04090-z.

DOI:10.1007/s11274-024-04090-z
PMID:39073503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11286680/
Abstract

The accelerated spread of antimicrobial-resistant bacteria has caused a serious health problem and rendered antimicrobial treatments ineffective. Innovative approaches are crucial to overcome the health threat posed by resistant pathogens and prevent the emergence of untreatable infections. Triggering stress responses in bacteria can diminish susceptibility to various antimicrobials by inducing resistance mechanisms. Therefore, a thorough understanding of stress response control, especially in relation to antimicrobial resistance, offers valuable perspectives for innovative and efficient therapeutic approaches to combat antimicrobial resistance. The aim of this study was to evaluate the stress responses of 8 different bacteria by analyzing reporter metabolites, around which significant alterations were observed, using a pathway-driven computational approach. For this purpose, the transcriptomic data that the bacterial pathogens were grown under 11 different stress conditions mimicking the human host environments were integrated with the genome-scale metabolic models of 8 pathogenic species (Enterococcus faecalis OG1R, Escherichia coli EPEC O127:H6 E2348/69, Escherichia coli ETEC H10407, Escherichia coli UPEC 536, Klebsiella pneumoniae MGH 78578, Pseudomonas aeruginosa PAO1, Staphylococcus aureus MRSA252, and Staphylococcus aureus MSSA476). The resulting reporter metabolites were enriched in multiple metabolic pathways, with cofactor biosynthesis being the most important. The results of this study will serve as a guide for the development of antimicrobial agents as they provide a first insight into potential drug targets.

摘要

抗菌药物耐药菌的加速传播造成了严重的健康问题,使抗菌药物治疗无效。创新方法对于克服耐药病原体带来的健康威胁和防止无法治疗的感染至关重要。在细菌中引发应激反应可以通过诱导耐药机制来降低对各种抗菌药物的敏感性。因此,深入了解应激反应控制,特别是与抗菌药物耐药性相关的应激反应控制,为对抗抗菌药物耐药性提供了有价值的创新和有效的治疗方法的视角。本研究的目的是通过分析报告代谢物来评估 8 种不同细菌的应激反应,在使用基于途径的计算方法时,观察到报告代谢物周围有显著的变化。为此,将模拟人类宿主环境的 11 种不同应激条件下生长的细菌病原体的转录组数据与 8 种病原体物种的基因组规模代谢模型(粪肠球菌 OG1R、大肠杆菌 EPEC O127:H6 E2348/69、大肠杆菌 ETEC H10407、大肠杆菌 UPEC 536、肺炎克雷伯菌 MGH 78578、铜绿假单胞菌 PAO1、金黄色葡萄球菌 MRSA252 和金黄色葡萄球菌 MSSA476)进行了整合。由此产生的报告代谢物在多个代谢途径中富集,其中辅酶生物合成最为重要。本研究的结果将为抗菌药物的开发提供指导,因为它们为潜在的药物靶点提供了初步的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e208/11286680/9e389130ad7f/11274_2024_4090_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e208/11286680/ea3568604032/11274_2024_4090_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e208/11286680/c57d39b325b2/11274_2024_4090_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e208/11286680/fe02c2e6d654/11274_2024_4090_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e208/11286680/9e389130ad7f/11274_2024_4090_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e208/11286680/ea3568604032/11274_2024_4090_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e208/11286680/c57d39b325b2/11274_2024_4090_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e208/11286680/fe02c2e6d654/11274_2024_4090_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e208/11286680/9e389130ad7f/11274_2024_4090_Fig4_HTML.jpg

相似文献

1
Unraveling bacterial stress responses: implications for next-generation antimicrobial solutions.解析细菌应激反应:对新一代抗菌解决方案的启示。
World J Microbiol Biotechnol. 2024 Jul 29;40(9):285. doi: 10.1007/s11274-024-04090-z.
2
Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.中国 ISPED 项目报告的 2016 至 2020 年儿童细菌流行病学和抗菌药物耐药性特征。
Microbiol Spectr. 2021 Dec 22;9(3):e0028321. doi: 10.1128/Spectrum.00283-21. Epub 2021 Nov 3.
3
Design SMAP29-LysPA26 as a Highly Efficient Artilysin against Pseudomonas aeruginosa with Bactericidal and Antibiofilm Activity.设计 SMAP29-LysPA26 作为一种针对铜绿假单胞菌的高效溶菌酶,具有杀菌和抗生物膜活性。
Microbiol Spectr. 2021 Dec 22;9(3):e0054621. doi: 10.1128/Spectrum.00546-21. Epub 2021 Dec 8.
4
Changing epidemiology and antimicrobial resistance of bacteria causing bacteremia in Taiwan: 2002-2020.2002 - 2020年台湾地区引起菌血症的细菌流行病学及抗菌药物耐药性变化
Microbiol Spectr. 2024 Aug 6;12(8):e0060824. doi: 10.1128/spectrum.00608-24. Epub 2024 Jun 25.
5
Evaluation of Antimicrobial Peptides from the Black Soldier Fly () against a Selection of Human Pathogens.黑皮蠹()来源抗菌肽对一系列人体病原体的评估。
Microbiol Spectr. 2022 Feb 23;10(1):e0166421. doi: 10.1128/spectrum.01664-21. Epub 2022 Jan 5.
6
Antimicrobial susceptibility profiles of gram-negative bacteria causing infections collected across India during 2014-2016: Study for monitoring antimicrobial resistance trend report.2014 - 2016年期间在印度各地收集的引起感染的革兰氏阴性菌的抗菌药敏谱:监测抗菌药物耐药性趋势报告的研究
Indian J Med Microbiol. 2018 Jan-Mar;36(1):32-36. doi: 10.4103/ijmm.IJMM_17_415.
7
Current trends in antimicrobial resistance of ESKAPEEc pathogens from bloodstream infections - Experience of a tertiary care centre in North India.血流感染中ESKAPEEc病原体的抗菌药物耐药性当前趋势——印度北部一家三级护理中心的经验
Indian J Med Microbiol. 2024 Jul-Aug;50:100647. doi: 10.1016/j.ijmmb.2024.100647. Epub 2024 Jun 14.
8
Identification of a copper-responsive small molecule inhibitor of uropathogenic .鉴定一种铜反应小分子抑制剂对尿路致病性 。
J Bacteriol. 2024 Jul 25;206(7):e0011224. doi: 10.1128/jb.00112-24. Epub 2024 Jun 10.
9
Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008).加拿大医院中抗微生物药物耐药病原体的流行情况:加拿大病房监测研究(CANWARD 2008)的结果。
Antimicrob Agents Chemother. 2010 Nov;54(11):4684-93. doi: 10.1128/AAC.00469-10. Epub 2010 Aug 30.
10
A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.全细胞筛选发现与多粘菌素协同作用并具有抗多重耐药菌活性的小分子生物活性物质。
Antimicrob Agents Chemother. 2020 Feb 21;64(3). doi: 10.1128/AAC.01677-19.

引用本文的文献

1
Salmonella stress response systems as targets for anti-virulence strategies.沙门氏菌应激反应系统作为抗毒力策略的靶点。
BMC Microbiol. 2025 Jul 2;25(1):378. doi: 10.1186/s12866-025-04003-6.
2
Insight into antistaphylococcal effect of chlorinated 1-hydroxynaphthalene-2-carboxanilides.对氯化1-羟基萘-2-甲酰苯胺抗葡萄球菌作用的洞察。
ADMET DMPK. 2025 Mar 26;13(2):2684. doi: 10.5599/admet.2684. eCollection 2025.

本文引用的文献

1
The antibiotic crisis: On the search for novel antibiotics and resistance mechanisms.抗生素危机:探寻新型抗生素及耐药机制
Microb Biotechnol. 2024 Mar;17(3):e14430. doi: 10.1111/1751-7915.14430.
2
Use of a combined antibacterial synergy approach and the ANNOgesic tool to identify novel targets within the gene networks of multidrug-resistant .采用联合抗菌协同作用方法和 ANNOgesic 工具,鉴定多重耐药基因网络中的新靶标。
mSystems. 2024 Mar 19;9(3):e0087723. doi: 10.1128/msystems.00877-23. Epub 2024 Feb 13.
3
Enzymes in riboflavin biosynthesis: Potential antibiotic drug targets.
核黄素生物合成中的酶:潜在的抗生素药物靶点。
Arch Biochem Biophys. 2023 Oct 15;748:109762. doi: 10.1016/j.abb.2023.109762. Epub 2023 Sep 20.
4
MBROLE3: improved functional enrichment of chemical compounds for metabolomics data analysis.MBROLE3:改进代谢组学数据分析中化合物的功能富集。
Nucleic Acids Res. 2023 Jul 5;51(W1):W305-W309. doi: 10.1093/nar/gkad405.
5
Application of cofactors in the regulation of microbial metabolism: A state of the art review.辅助因子在微生物代谢调控中的应用:最新综述
Front Microbiol. 2023 Apr 11;14:1145784. doi: 10.3389/fmicb.2023.1145784. eCollection 2023.
6
Food for thought: Opportunities to target carbon metabolism in antibacterial drug discovery.值得深思的是:在抗菌药物研发中靶向碳代谢的机会。
Ann N Y Acad Sci. 2023 Jun;1524(1):51-64. doi: 10.1111/nyas.14991. Epub 2023 Apr 2.
7
Mycobacterial MenG: Partial Purification, Characterization, and Inhibition.分枝杆菌 MenG:部分纯化、表征和抑制。
ACS Infect Dis. 2022 Dec 9;8(12):2430-2440. doi: 10.1021/acsinfecdis.2c00190. Epub 2022 Nov 23.
8
KEGG for taxonomy-based analysis of pathways and genomes.KEGG 用于基于分类的途径和基因组分析。
Nucleic Acids Res. 2023 Jan 6;51(D1):D587-D592. doi: 10.1093/nar/gkac963.
9
Bacterial Stress Responses as Potential Targets in Overcoming Antibiotic Resistance.细菌应激反应作为克服抗生素耐药性的潜在靶点
Microorganisms. 2022 Jul 9;10(7):1385. doi: 10.3390/microorganisms10071385.
10
Leaks in the Pipeline: a Failure Analysis of Gram-Negative Antibiotic Development from 2010 to 2020.管中窥豹:2010 至 2020 年革兰氏阴性抗生素研发失败案例分析。
Antimicrob Agents Chemother. 2022 May 17;66(5):e0005422. doi: 10.1128/aac.00054-22. Epub 2022 Apr 26.